Cyclopropylamines as LSD1 inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11247992
APP PUB NO 20210032244A1
SERIAL NO

16897051

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INCYTE HOLDINGS CORPORATION1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
INCYTE CORPORATION1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Courter, Joel R Glen Mills, US 17 410
He, Chunhong Boothwyn, US 102 2747
Wang, Xiaozhao Mt. Laurel, US 87 982
Wu, Liangxing Wilmington, US 162 5431
Yao, Wenqing Chadds Ford, US 324 9447
Zhang, Fenglei Berwyn, US 59 1996

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 15, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 15, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 15, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00